317 related articles for article (PubMed ID: 28961067)
1. Precision Medicine Is Not Just Genomics: The Right Dose for Every Patient.
Peck RW
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():105-122. PubMed ID: 28961067
[TBL] [Abstract][Full Text] [Related]
2. Drug development in the era of precision medicine.
Dugger SA; Platt A; Goldstein DB
Nat Rev Drug Discov; 2018 Mar; 17(3):183-196. PubMed ID: 29217837
[TBL] [Abstract][Full Text] [Related]
3. The right dose for every patient: a key step for precision medicine.
Peck RW
Nat Rev Drug Discov; 2016 Mar; 15(3):145-6. PubMed ID: 26669674
[TBL] [Abstract][Full Text] [Related]
4. Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration-Approved Drugs.
Schuck RN; Pacanowski M; Kim S; Madabushi R; Zineh I
Clin Transl Sci; 2019 May; 12(3):236-239. PubMed ID: 30791226
[TBL] [Abstract][Full Text] [Related]
5. The future of precision medicine: towards a more predictive personalized medicine.
Elemento O
Emerg Top Life Sci; 2020 Sep; 4(2):175-177. PubMed ID: 32856697
[TBL] [Abstract][Full Text] [Related]
6. Cancer Precision Medicine: Why More Is More and DNA Is Not Enough.
Schütte M; Ogilvie LA; Rieke DT; Lange BMH; Yaspo ML; Lehrach H
Public Health Genomics; 2017; 20(2):70-80. PubMed ID: 28595192
[TBL] [Abstract][Full Text] [Related]
7. Transplantomics: Toward Precision Medicine in Transplantation Research.
Sirota M; Sarwal MM
Transplantation; 2017 Aug; 101(8):1777-1782. PubMed ID: 28121910
[TBL] [Abstract][Full Text] [Related]
8. Lifestyle and precision diabetes medicine: will genomics help optimise the prediction, prevention and treatment of type 2 diabetes through lifestyle therapy?
Franks PW; Poveda A
Diabetologia; 2017 May; 60(5):784-792. PubMed ID: 28124081
[TBL] [Abstract][Full Text] [Related]
9. Precision Dosing: An Industry Perspective.
Peck RW
Clin Pharmacol Ther; 2021 Jan; 109(1):47-50. PubMed ID: 33107023
[No Abstract] [Full Text] [Related]
10. Toward Dynamic Prescribing Information: Codevelopment of Companion Model-Informed Precision Dosing Tools in Drug Development.
Polasek TM; Rayner CR; Peck RW; Rowland A; Kimko H; Rostami-Hodjegan A
Clin Pharmacol Drug Dev; 2019 May; 8(4):418-425. PubMed ID: 30500115
[TBL] [Abstract][Full Text] [Related]
11. Personalized reproductive medicine: regulatory considerations.
Jarow JP
Fertil Steril; 2018 Jun; 109(6):964-967. PubMed ID: 29935654
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Assessment of US Food and Drug Administration Dosing Recommendations For Drug Development Programs Amenable to Response-Guided Titration.
Wang L; Maxfield K; Guinn D; Madabushi R; Zineh I; Schuck RN
Clin Pharmacol Ther; 2021 Jan; 109(1):123-130. PubMed ID: 33022770
[TBL] [Abstract][Full Text] [Related]
13. The mathematics of drug dose individualization should be built with random-effects linear models.
Diaz FJ; de Leon J
Ther Drug Monit; 2013 Apr; 35(2):276-7. PubMed ID: 23503456
[No Abstract] [Full Text] [Related]
14. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
Lauschke VM; Ingelman-Sundberg M
Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
[TBL] [Abstract][Full Text] [Related]
15. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
16. A Critique of Pharmacokinetic Calculators for Drug Dosing Individualization.
Janković SM
Eur J Drug Metab Pharmacokinet; 2020 Apr; 45(2):157-162. PubMed ID: 31773426
[TBL] [Abstract][Full Text] [Related]
17. Response to Diaz and de Leon "the mathematics of drug dose individualization should be built with random effects linear models".
Holford NH; Buclin T
Ther Drug Monit; 2013 Dec; 35(6):873-4. PubMed ID: 24263647
[No Abstract] [Full Text] [Related]
18. Physiologically-Based Pharmacokinetic Models as Enablers of Precision Dosing in Drug Development: Pivotal Role of the Human Mass Balance Study.
Rowland Yeo K; Venkatakrishnan K
Clin Pharmacol Ther; 2021 Jan; 109(1):51-54. PubMed ID: 33220063
[No Abstract] [Full Text] [Related]
19. The FDA Oncology Center of Excellence and precision medicine.
Goldberg KB; Blumenthal GM; McKee AE; Pazdur R
Exp Biol Med (Maywood); 2018 Feb; 243(3):308-312. PubMed ID: 29105511
[TBL] [Abstract][Full Text] [Related]
20. Human genomics projects and precision medicine.
Carrasco-Ramiro F; Peiró-Pastor R; Aguado B
Gene Ther; 2017 Sep; 24(9):551-561. PubMed ID: 28805797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
